Identification of a Specific Motif of the DSS1 Protein Required for Proteasome Interaction and p53 Protein Degradation

Journal of Molecular Biology

Volumn 383, Issue 3, 2008, Pages 693-712

  Wei, Sung Jen ^a,c   Williams, Jason G ^a   Dang, Hong ^b   Darden, Thomas A ^a   Betz, Bryan L ^a   Humble, Margaret M ^a   Chang, Fang Mei ^a,c   Trempus, Carol S ^a   Johnson, Katina ^a   Cannon, Ronald E ^a   Tennant, Raymond W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Alpha Gamma Technologies Inc   (United States)

^c Medical Research Division   (United States)

Author keywords

DSS1; p53; RPN3 S3; siRNA; Ubiquitin proteasome system

Indexed keywords

AMINO ACID; BINDING PROTEIN; PROTEASOME; PROTEIN DSS1; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOSOL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN TARGETING; UBIQUITINATION;

NEMATODA;

EID: 52949126319     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.08.044     Document Type: Article

References (62)

1. Crackower M.A., Scherer S.W., Rommens J.M., Hui C.C., Poorkaj P., Soder S., et al. Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum. Mol. Genet. 5 (1996) 571-579
2. Zlotogora J. On the inheritance of the split hand/split foot malformation. Am. J. Med. Genet. 53 (1994) 29-32
3. Jäntti J., Lahdenranta J., Olkkonen V.M., Söderlund H., and Keränen S. SEM1, a homologue of the split hand/split foot malformation candidate gene Dss1, regulates exocytosis and pseudohyphal differentiation in yeast. Proc. Natl Acad. Sci. USA 96 (1999) 909-914
4. Marston N.J., Richards W.J., Hughes D., Bertwistle D., Marshall C.J., and Ashworth A. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol. Cell. Biol. 19 (1999) 4633-4642
5. Yang H., Jeffrey P.D., Miller J., Kinnucan E., Sun Y., Thomä N.H., et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297 (2002) 1837-1848
6. Kojic M., Yang H., Kostrub C.F., Pavletich N.P., and Holloman W.K. The BRCA2-interacting protein DSS1 is vital for DNA repair, recombination, and genome stability in Ustilago maydis. Mol. Cell 12 (2003) 1043-1049
7. Gudmundsdottir K., Lord C.J., Witt E., Tutt A.N.J., and Ashworth A. DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells. EMBO Rep. 5 (2004) 1-5
8. Krogan N.J., Lam M.H.Y., Fillingham J., Keogh M.-C., Gebbia M., Li J., et al. Proteasome involvement in the repair of DNA double-strand breaks. Mol. Cell 16 (2004) 1027-1034
9. Kojic M., Zhou Q., Lisby M., and Holloman W.K. Brh2-Dss1 interplay enables properly controlled recombination in Ustilago maydis. Mol. Cell. Biol. 25 (2005) 2547-2557
10. Li J., Zou C., Bai Y., Wazer D.E., Band V., and Gao Q. DSS1 is required for the stability of BRCA2. Oncogene 25 (2006) 1186-1194
11. Zhou Q., Kojic M., Cao Z., Lisby M., Mazloum N.A., and Holloman W.K. Dss1 Interaction with Brh2 as a Regulatory Mechanism for Recombinational Repair. Mol. Cell. Biol. 27 (2007) 2512-2526
12. Wei S.-J., Trempus C.S., Cannon R.E., Botner C.D., and Tennant R.W. Identification of Dss1 as a 12-O-tetradecanoylphorbol-13-acetate-responsive gene expressed in keratinocyte progenitor cells, with possible involvement in early skin tumorigenesis. J. Biol. Chem. 278 (2003) 1758-1768
13. Funakoshi M., Li X., Velichutina I., Hochstrasser M., and Kobayashi H. Sem1, the yeast ortholog of a human BRCA2-binding protein, is a component of the proteasome regulatory particle that enhances proteasome stability. J. Cell Sci. 117 (2004) 6447-6454
14. Sone T., Saeki Y., Toh-e A., and Yokosawa H. Sem1p is a novel subunit of the 26S proteasome from Saccharomyces cerevisiae. J. Biol. Chem. 279 (2004) 28807-28816
15. Thakurta A.G., Gopal G., Yoon J.H., Kozak L., and Dhar R. Homolog of Brca2-interacting Dss1p and Uap56p link Mlo3p and Rae1p for mRNA export in fission yeast. EMBO J. 24 (2005) 2512-2523
16. Rundhaug J.E., Hawkins K.A., Pavone A., Gaddis S., Kil H., Klein R.D., et al. SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Mol. Carcinog. 42 (2005) 40-52
17. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65 (1996) 801-847
18. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
19. Voges D., Zwickl P., and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68 (1999) 1015-1068
20. Wojcik C., Tanaka K., Paweletz N., Naab U., and Wilk S. Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLaS3 cells. Eur. J. Cell Biol. 77 (1998) 151-160
21. Schmidt M., Lupas A.N., and Finley D. Structure and mechanism of ATP-dependent proteases. Curr. Opin. Chem. Biol. 3 (1999) 584-591
22. McCutchen-Maloney S.L., Matsuda K., Shimbara N., Binns D.D., Tanaka K., Slaughter C.A., et al. cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome. J. Biol. Chem. 275 (2000) 18557-18565
23. Ustrell V., Hoffman L., Pratt G., and Rechsteiner M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21 (2002) 3516-3525
24. Schwartz A.L., and Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50 (1999) 57-74
25. Ciechanover A., and Iwai K. The ubiquitin system: from basic mechanisms to the patient bed. IUBMB Life 56 (2004) 193-201
26. Baumeister W., Walz J., Zuhl F., and Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92 (1998) 367-380
27. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5 (2004) 417-421
28. Glickman M.H., Rubin D.M., Fried V.A., and Finley D. The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol. Cell. Biol. 18 (1998) 3149-3162
29. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882
30. Baillat D., Hakimi M., Näär A., Shilatifard A., Cooch N., and Shiekhattar R. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123 (2005) 265-276
31. Jossé L., Harley M.E., Pires I.M.S., and Hughes D.A. Fission yeast Dss1 associates with the proteasome and is required for efficient ubiquitin-dependent proteolysis. Biochem. J. 393 (2006) 303-309
32. Higashitsuji H., Itoh K., Nagao T., Dawson S., Nonoguchi K., Kido T., et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein over-expressed in hepatomas. Nat. Med. 6 (2000) 96-99
33. Higashitsuji H., Higashitsuji H., Itoh K., Sakurai T., Nagao T., Sumitomo Y., et al. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 8 (2005) 75-87
34. Dawson S., Higashitsuji H., Wilkinson A.J., Fujita J., and Mayer R.J. Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol. 16 (2006) 229-233
35. Nakamura Y., Umehara T., Tanaka A., Horikoshi M., Padmanabhan B., and Yokoyam S. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome. Biochem. Biophys. Res. Commun. 359 (2007) 503-509
36. Kawai H., Wiederschain D., and Yuan Z.-M. Critical contribution of the Mdm2 acidic domain to p53 ubiquitinylation. Mol. Cell. Biol. 23 (2003) 4939-4947
37. Meulmeester E., Frenk R., Stad R., de Graaf P., Marine J.-C., Vousden K.H., et al. Critical role for a central part of Mdm2 in the ubiquitinylation of p53. Mol. Cell. Biol. 23 (2003) 4929-4938
38. Deveraux Q., Ustrell V., Pickart C., and Rechsteiner M. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269 (1994) 7059-7061
39. Braun B.C., Glickman M., Kraft R., Dahlmann B., Kloetzel P.M., Finley D., et al. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell Biol. 1 (1999) 221-226
40. Kohler A., Cascio P., Legget D.S., Woo K.M., Goldberg A.L., and Finley D. The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol. Cell 7 (2001) 1143-1152
41. Verma R., Aravind L., Oania R., McDonald W.H., Yates III J.R., Koonin E.V., et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298 (2002) 611-615
42. Yao T., and Cohen R.E. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419 (2002) 403-407
43. Ferrell K., Wilkinson C.R.M., Dubiel W., and Gordon C. Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem. Sci. 25 (2000) 83-88
44. Fu H., Reis N., Lee Y., Glickman M.H., and Vierstra R.D. Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J. 20 (2001) 7096-7107
45. Sharon M., Taverner T., Ambroggio X.I., Deshaies R.J., and Robinson C.V. Structural organization of the 19S proteasome lid: insights from MS of intact complexes. PLOS Biol. 4 (2006) 1314-1323
46. Gudmundsdottir K., Lord C.J., and Ashworth A. The proteasome is involved in determining differential utilization of double-strand break repair pathways. Oncogene 26 (2007) 7601-7606
47. Fehlker M., Wendler P., Lehmann A., and Enenkel C. Blm3 is part of nascent proteasomes and is involved in a late stage of nuclear proteasome assembly. EMBO Rep. 4 (2003) 959-963
48. Schmidt M., Haas W., Crosas B., Santamaria P.G., Gygi S.P., Walz T., et al. The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle. Nat. Struct. Mol. Biol. 12 (2005) 294-303
49. Hoffmann K., and Bucher P. The PCI domain: a common theme in three multiprotein complexes. Trends Biochem. Sci. 23 (1998) 204-205
50. Young P., Deveraux Q., Beal R.E., Pickart C.M., and Rechsteiner M. Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a. J. Biol. Chem. 273 (1998) 5461-5467
51. Funakoshi M., Sasaki T., Nishimoto T., and Kobayashi H. Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome. Proc. Natl Acad. Sci. USA 99 (2002) 745-750
52. Lam Y.A., Lawson T.G., Velayutham M., Zweier J.L., and Pickart C.M. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 416 (2002) 763-767
53. Elsasser S., Chandler-Militello D., Mueller B., Hanna J., and Finley D. Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J. Biol. Chem. 279 (2004) 26817-26822
54. Verma R., Oania R., Graumann J., and Deshaies R.J. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118 (2004) 99-110
55. Verma R., Peters N.R., D'Onofrio M., Tochtrop G.P., Sakamoto K.M., Varadan R., et al. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science 306 (2004) 117-120
56. Yang Y., Ludwig R.L., Jensen J.P., Pierre S.A., Medaglia M.V., Davydov I.V., et al. Small molecule inhibitor of HDM2 ubiquitin ligase activity stabilizes and activates p53 in cells. Cancer Cell 7 (2005) 547-559
57. Buolamwini J.K., Addo J., Kamath S., Patil S., Mason M., and Ores M. Small molecule antagonists of the MDM2 oncoprotein as anticancer agents. Curr. Cancer Drug Targets 5 (2005) 57-68
58. Issaeva N., Bozko P., Enge M., Protopopova M., Verhoef L.G.G.C., Masucci M., et al. Small molecule RITA binds to p53, blocks p53-HDM2 interaction and activates p53 function in tumors. Nat. Med. 10 (2004) 1321-1328
59. Kharrat N., Ayadi I., and Rebayi{cyrillic} A. Sample size computation for association studies using case-parents design. J. Genet. 85 (2006) 187-191
60. Deterding L.J., Prasad R., Mullen G.P., Wilson S.H., and Tomer K.B. Mapping of the 5′-2′-deoxyribose-5′-phosphate lyase active site in DNA polymerase β by mass spectrometry. J. Biol. Chem. 275 (2000) 10463-10471
61. Yuan Z.-M., Huang Y., Kraeft S.K., Chen L.B., Kharbanda S., and Kufe D. Interaction of cyclin-dependent kinase 2 and Lyn tyrosine kinase in cells treated with 1-β-D-arabinofuranosylcytosine. Oncogene 13 (1996) 939-946
62. Cuff J.A., and Barton G.J. Application of enhanced multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins 40 (1999) 502-511